193 related articles for article (PubMed ID: 12211218)
1. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
Ishii Y; Nakamura K; Matsuki S; Uemura N; Muraguchi R; Nakagawa M; Nakano S; Nakatsuka K
J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
3. [Effect of 8-hydroxycarteolol in normal human eyes].
Kato Y; Sasaki T; Tsukahara S
Nippon Ganka Gakkai Zasshi; 1992 Jul; 96(7):899-903. PubMed ID: 1354411
[TBL] [Abstract][Full Text] [Related]
4. [Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product].
Yamamoto T;
Nippon Ganka Gakkai Zasshi; 2007 Jun; 111(6):463-72. PubMed ID: 17601060
[TBL] [Abstract][Full Text] [Related]
5. Effect of topical carteolol on the normal human retinal circulation.
Grunwald JE; Delehanty J
Invest Ophthalmol Vis Sci; 1992 May; 33(6):1853-6. PubMed ID: 1582788
[TBL] [Abstract][Full Text] [Related]
6. Topical verapamil and episcleral venous pressure.
Abreu MM; Kim YY; Shin DH; Netland PA
Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
Uusitalo H; Niño J; Tahvanainen K; Turjanmaa V; Ropo A; Tuominen J; Kähönen M
Acta Ophthalmol Scand; 2005 Dec; 83(6):723-8. PubMed ID: 16396651
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical beta-blockers on tissue blood flow in the human optic nerve head.
Tamaki Y; Araie M; Tomita K; Nagahara M; Tomidokoro A
Curr Eye Res; 1997 Nov; 16(11):1102-10. PubMed ID: 9395769
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical carteolol on tissue circulation in the optic nerve head.
Tamaki Y; Araie M; Tomita K; Tomidokoro A
Jpn J Ophthalmol; 1998; 42(1):27-32. PubMed ID: 9507362
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical adrenergic agents on tissue circulation in rabbit and human optic nerve head evaluated with laser speckle tissue circulation analyzer.
Tamaki Y; Araie M; Tomita K; Tomidokoro A; Nagahara M
Surv Ophthalmol; 1997 Nov; 42 Suppl 1():S52-63. PubMed ID: 9603290
[TBL] [Abstract][Full Text] [Related]
11. Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.
Renard P; Kovalski JL; Cochereau I; Jaulerry S; Williamson W; Elena PP; Lablache Combier M; Allaire C; Siou-Mermet R
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1221-7. PubMed ID: 16003515
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical carteolol on iridial circulation in pigmented rabbit eyes.
Tomidokoro A; Tamaki Y; Araie M; Tomita K; Muta K
Jpn J Ophthalmol; 1998; 42(3):180-5. PubMed ID: 9690895
[TBL] [Abstract][Full Text] [Related]
13. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
Korte JM; Kaila T; Saari KM
Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.
Ohtori R; Sato H; Fukuda S; Ueda T; Koide R; Kanda Y; Kiuchi Y; Oguchi K
Exp Eye Res; 1998 Apr; 66(4):487-94. PubMed ID: 9593641
[TBL] [Abstract][Full Text] [Related]
15. Effects of topical carteolol and timolol on tissue circulation in the iris and choroid.
Tomidokoro A; Araie M; Tamaki Y; Muta K
Curr Eye Res; 1999 May; 18(5):381-90. PubMed ID: 10373001
[TBL] [Abstract][Full Text] [Related]
16. [Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
Schnarr KD
Klin Monbl Augenheilkd; 1988 Feb; 192(2):167-72. PubMed ID: 2896266
[TBL] [Abstract][Full Text] [Related]
17. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration].
Kawase K; Yamamoto T; Muramatsu T; Ono J; Nakajima T; Matsuhisa A; Sugiura T; Migita M; Ishikawa Y
Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):976-82. PubMed ID: 21141077
[TBL] [Abstract][Full Text] [Related]
18. Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma.
Nakamoto K; Yasuda N
Jpn J Ophthalmol; 2010 Mar; 54(2):140-3. PubMed ID: 20401563
[TBL] [Abstract][Full Text] [Related]
19. Acute effect of topical carteolol on ocular pulsatile volume change.
Yamazaki S; Baba H
Acta Ophthalmol (Copenh); 1993 Dec; 71(6):760-4. PubMed ID: 8154249
[TBL] [Abstract][Full Text] [Related]
20. Ocular hypotensive efficacy and safety of once daily carteolol alginate.
Demailly P; Allaire C; Trinquand C;
Br J Ophthalmol; 2001 Aug; 85(8):921-4. PubMed ID: 11466245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
